menu
    • menu

    Company profile for Pint Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Pint Pharma, we strive to make the lives of Latin American patients with rare diseases better by providing prompt and reliable access to cutting-edge therapies. We source innovative patent-protected biotechnologies with the potential to transform patient outcomes in areas of significant unmet need, and make them available region wide through our comprehensive and robust commercialization platform. Today, we count with ne...
    At Pint Pharma, we strive to make the lives of Latin American patients with rare diseases better by providing prompt and reliable access to cutting-edge therapies. We source innovative patent-protected biotechnologies with the potential to transform patient outcomes in areas of significant unmet need, and make them available region wide through our comprehensive and robust commercialization platform. Today, we count with nearly 250 ambitious individuals and 8 offices around the globe including: Austria (HQ), Argentina, Brazil, Chile, Colombia, Ecuador, Mexico and Peru.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pint PharmaAustria Flag
    Country
    Country
    Austria
    Address
    Address
    Wipplingerstraße 34 Top 112-119 1010 Vienna
    Telephone
    Telephone
    +43 (0)1 259 47 35
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pint-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pint-pharma/?originalSubdomain=at
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Invima Approves ORLADEYO for HAE Prevention in Colombia
    Invima Approves ORLADEYO for HAE Prevention in Colombia

    26 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250626757988/en/Pint-Pharma-Announces-INVIMAs-Approval-of-ORLADEYO-berotralstat-the-First-Oral-Therapy-for-Preventing-Hereditary-Angioedema-HAE-Attacks-in-Patients-Aged-12-and-Older-in-Colombia

    BUSINESSWIRE
    26 Jun 2025
    Share Share
    ORLADEYO® (berotralstat) Approved in Colombia
    ORLADEYO® (berotralstat) Approved in Colombia

    13 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/13/3098930/29446/en/ORLADEYO-berotralstat-Approved-in-Colombia.html

    GLOBENEWSWIRE
    13 Jun 2025
    Share Share
    Pint Pharma Gets ANVISA Nod For Besremi In Polycythemia Vera
    Pint Pharma Gets ANVISA Nod For Besremi In Polycythemia Vera

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250320323757/en/Pint-Pharma-Announces-ANVISAs-Approval-of-BESREMi-ropeginterferon-alfa-2b-for-the-Treatment-of-Polycythemia-Vera

    BUSINESSWIRE
    20 Mar 2025
    Share Share
    Pint Pharma Announces ORLADEYO Approval For HAE In Peru
    Pint Pharma Announces ORLADEYO Approval For HAE In Peru

    09 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240708657663/en

    BUSINESSWIRE
    09 Jul 2024
    Share Share
    Pint Pharma announces Orladeyo approval in Mexico for HAE prevention
    Pint Pharma announces Orladeyo approval in Mexico for HAE prevention

    14 May 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/pint-pharma-orladeyo-mexico/

    PHARMACEUTICAL TECHNOLOGY
    14 May 2024
    Share Share
    Pint Pharma Announces ORLADEYO Approval In Mexico For HAE
    Pint Pharma Announces ORLADEYO Approval In Mexico For HAE

    13 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240513238668/en

    BUSINESSWIRE
    13 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search